INTRODUCTION {#sec1-1}
============

The genus *Wikstroemia* (Thymelaeaceae) comprising approximately 70 species is widely distributed in northern Asia through the Himalayas, Malaysia, Oceania, Polynesia to the Hawaiian Islands.\[[@ref1]\] In China, about 44 species have been found mainly in the south of the Yangtze River. *Wikstroemia scytophylla* Diels is regionally distributed in the provinces of Yunnan, Sichuan, and Tibet in China. There is no report about the bioactivity of *W. scytophylla*. *Wikstroemia indica*, the same genus with *W. scytophylla*, has long been used as a traditional crude drug for the treatment of pneumonia, rheumatism, and bronchitis in China.\[[@ref2]\]

Previous phytochemical studies on *W. scytophylla*, which has been investigated only by our group, have resulted in the isolation and identification of flavones (including biflavones), coumarins, sesquiterpene, and diterpene esters.\[[@ref3][@ref4]\]

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

The stems of *W. scytophylla* were collected in May, 2015, in Diqing Tibetan Autonomous Prefecture, Yunnan Province, China, and identified by Professor Liang-Ke Song (Southwest Jiaotong University). Voucher specimen (JHZ-201505) was deposited at the Natural Products Chemistry Laboratory, Southwest Jiaotong University, China.

Extraction and isolation {#sec2-2}
------------------------

The dried and powdered stems of *W. scytophylla* (5.0 kg) were extracted with 95% EtOH under reflux for three times (3 × 15 L). The extract was concentrated and suspended in water followed by successive partition with petroleum ether (3 × 5 L), EtOAc (3 × 5 L), and *n*-BuOH (3 × 5 L).

The EtOAc extract (380 g) was chromatographed over silica gel (3.8 kg, 200--300 mesh) using a gradient solvent petroleum ether/acetone (100:1-1:1) to afford nine fractions. Fraction 3 (42 g) was subjected to silica gel column using a gradient solvent petroleum ether/EtOAc (20:1-0:1) to afford fractions 3-1 - 3-8. Fraction 3-3 (2.9 g) was separated on Sephadex LH-20 (CHCl~3~/MeOH 1:1) to give compounds 3 (19 mg) and 7 (15 mg). Fraction 3-4 (14.1 g) gel filtrated on Sephadex LH-20 (CHCl~3~/MeOH 1:1) to give six subfractions (3-4-1 -- 3-4-6). Fraction 3-4-3 (4.4 g) was further purified on repeated RP-18 (MeOH/H~2~O, 40%--100%) and Sephadex LH-20 (CHCl~3~/MeOH 1:1) to give compounds 6 (4 mg), 8 (28 mg), and 9 (143 mg). Fraction 3-5 (22.5 g) gel filtrated on Sephadex LH-20 (CHCl~3~/MeOH 1:1) to give five subfractions (3-5-1 -- 3-5-5). Fraction 3-5-3 (13.7 g) was further purified on repeated RP-18 (MeOH/H~2~O, 40%-100%) and Sephadex LH-20 (CHCl~3~/MeOH 1:1) to give compounds 2 (5 mg) and 4 (12 mg). Fraction 4 (118 g) was chromatographed on silica gel column using a gradient solvent petroleum ether/EtOAc (15:1-0:1) to give nine fractions (4-1 - 4-9). Fraction 4-4 (27.8 g) was further separated on repeated RP-18 (MeOH/H~2~O, 40%-100%) and Sephadex LH-20 (CHCl~3~/MeOH 1:1) to afford compounds 5 (11 mg), 10 (5 mg), and 11 (5 mg). Fraction 4-5 (16.5 g) was separated on silica gel column using a gradient solvent CHCl~3~/MeOH (30:1-1:1) to give seven fractions (4-5-1 - 4-5-7). Fraction 4-5-1 (302 mg) was further purified on Sephadex LH-20 (CHCl~3~/MeOH 1:1) to give 12 (2 mg). Further purification of 4-5-6 (1.58 g) was submitted to Sephadex LH-20 (CHCl~3~/MeOH 1:1) to yield 1 (6 mg).

Cytotoxicity bioassay {#sec2-3}
---------------------

The isolated compounds 1 and 7-12 were evaluated for their cytotoxicities against five human cell lines HL-60, SMMC-7721, A549, MCF-7, and SW480, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method\[[@ref5]\] with cisplatin (Sigma) and culture solution as positive and negative controls, respectively. Half maximal inhibitory (IC~50~) values were calculated by Reed and Muench\'s method.

RESULTS {#sec1-3}
=======

The structures of compounds 1-12 \[[Figure 1](#F2){ref-type="fig"}\] were identified as wikstrol B (1),\[[@ref6][@ref7]\] apigenin 7-*O*-methyl ether (2),\[[@ref8]\] apigenin 5, 7-dimethyl ether (3),\[[@ref9]\] luteolin 7, 4'-dimethyl ether (4),\[[@ref10]\] 5, 7-di-*O*-methylquercetin(5),\[[@ref11]\] 3'-hydroxy-4', 5, 7-trimethoxy-flavone (6),\[[@ref12]\] 3-(1, 3-benzodioxol-5-ylmethyl)-4-\[(3, 4-dimethoxyphenyl)methyl\]dihydro-, (3*S*-cis)-2(3H)-furanone (7),\[[@ref13][@ref14]\] 4-\[(*R*)-1, 3-benzodioxol-5-ylhydroxymethyl\]-3-(1, 3-benzodioxol-5-ylmethyl)dihydro-, (3*S*, 4*R*)-2(3H)-furanone (8),\[[@ref14][@ref15]\] (-)-dihydrosesamin (9),\[[@ref16]\] phenol, 4, 4'-\[(2*R*, 3*S*, 4*S*)-tetrahydro-2-methoxy-3, 4-furandiyl\]bis(methylene)\]bis\[2-methoxy- (10),\[[@ref17]\] 4, 4'-dihydroxy-3, 3', 9-trimethoxy-9, 9'-epoxylignan (11),\[[@ref17]\] (+)-1-hydroxypinoresinol (12),\[[@ref18][@ref19]\] respectively, by analysis of mass spectrometry and nuclear magnetic resonance (NMR) data, and comparison with those in the literature.

![Structures of compounds 1-12 isolated from *Wikstroemia scytophylla*](PM-13-488-g002){#F2}

As a continuation of our previous phytochemical investigation\[[@ref3][@ref4]\] of *W. scytophylla*, the present study reports a new natural product (8) along with 11 known compounds, including one biflavone (1), five flavones (2-6), and five lignans (7, 9-12). All these compounds were isolated from this plant for the first time, and compounds 2-12 were first reported from the genus *Wikstroemia*. According to the cytotoxicity bioassay results, compounds 1 and 7-12 exhibited weak antitumor activities (IC~50~ \>40 μM).

DISCUSSION {#sec1-4}
==========

The chemical constituents of the family Thymelaeaceae especially the genus *Daphne* and *Aquilaria* are characterized by terpenoids (sesquiterpenoids, daphnane-type diterpene ester), coumarins, flavonoids (flavones, isoflavones, biflavones), and lignans.\[[@ref20][@ref21][@ref22][@ref23][@ref24]\] The genus *Wikstroemia* has about 70 species, but only a limited number of species (*W. indica*, *W. chamaedaphne*, etc.) have been studied chemically, and *Wikstroemia* is also characterized by the occurrence of terpenoids, coumarins, flavonoids, and lignans, and the types of these reported compounds are very similar with those in the genus *Daphne*.\[[@ref3][@ref4][@ref25][@ref26][@ref27]\] Compounds 1-12 isolated in the current research were classified as biflavone (1), flavones (2-6), and lignans (7-12). The structural types of these isolates confirm the relationship between *W. scytophylla* and other species of *Wikstroemia*. The phytochemical study suggests that there is a close chemotaxonomic relationship between the genus *Wikstroemia*, *Aquilaria*, and *Daphne* in the family Thymelaeaceae. As flavonoids were widely present in *W. scytophylla* metabolites and isolated as the main type of components in the current study, while terpenoids, coumarins, and lignans were the main bioactive compositions in Thymelaeaceae, lignans could be used as chemotaxonomic markers for the species *W. scytophylla* according to this study. Moreover, it can also be concluded that lignans could be considered as chemotaxonomic markers of the genus *Wikstroemia*. The result of the present study also supports the conclusion of Zhang *et al*.\[[@ref20]\] that biflavonoids are characteristic constituents of the Thymelaeaceae family.

SUPPLEMENTARY DATA {#sec1-5}
==================

Flavones and lignans from the stems of *Wikstroemia scytophylla* Diels {#sec2-4}
----------------------------------------------------------------------

**^1^H and ^13^C NMR spectra of compounds 1-12**:

*Wikstrol B (1)*: C~30~H~22~O~10~, yellow powder, \[α\]20 D-31.4° (c = 0.16, MeOH); ^1^H NMR (400 MHz, CD~3~COCD~3~) δ: 7.56 (2H, d, *J* = 8.8 Hz, H-10'', H-14''), 6.86 (2H, d, *J* = 8.8 Hz, H-11'', H-13''), 6.83 (2H, d, *J* = 8.6 Hz, H-2', H-6'), 6.72 (2H, d, *J* = 8.6 Hz, H-3', H-5'), 6.38 (1H, d, *J* = 2.4 Hz, H-8''), 6.20 (1H, d, *J* = 2.4 Hz, H-6''), 6.16 (1H, s, H-6), 4.57 (1H, d, *J* = 7.8 Hz, H-2), 3.75 (1H, m, H-3), 2.81 (1H, dd, *J* = 16.0 Hz, 5.2 Hz, H-4a), 2.58 (1H, dd, *J* = 16.0 Hz, 8.4 Hz, H-4b); ^13^ C NMR (100 MHz, CD~3~COCD~3~) δ: 181.2 (s, C-4''), 164.8 (s, C-7''), 163.3 (s, C-2''), 163.3 (s, C-5''), 160.2 (s, C-12''), 158.6 (s, C-8a), 157.7 (s, C-4'), 157.1 (s, C-5), 156.0 (s, C-8a), 154.1 (s, C-7), 131.2 (s, C-1'), 131.1 (d, C-10'', C-14''), 129.1 (d, C-2', C-6'), 125.5 (s, C-9''), 115.6 (d, C-11'', C-13''), 115.5 (d, C-3', C-5'), 113.7 (s, C-3''), 104.8 (s, C-4''a), 100.7 (s, C-4a), 99.3 (s, C-8), 99.3 (d, C-6''), 96.2 (d, C-6), 94.1 (d, C-8''), 82.3 (d, C-2), 68.5 (d, C-3), 28.8 (t, C-4).

*Apigenin 7-O-methyl ether (2)*: C~16~H~12~O~5~, yellow powder; ^1^H NMR (500 MHz, CD~3~COCD~3~) δ: 7.96 (2H, d, *J* = 8.6 Hz, H-2', H-6'), 7.13 (2H, d, *J* = 8.6 Hz, H-3', H-5'), 6.74 (1H, s, H-3), 6.72 (1H, d, *J* = 1.6 Hz, H-8), 6.32 (1H, d, *J* = 1.5 Hz, H-6), 3.92 (3H, s, 7-OCH~3~); ^13^C NMR (100 MHz, CD~3~COCD~3~) δ: 182.5 (s, C-4), 166.4 (s, C-7), 165.2 (s, C-2), 162.9 (s, C-4'), 161.5 (s, C-5), 158.0 (s, C-9), 129.2 (d, C-2', C-6'), 119.5 (s, C-1'), 116.9 (d, C-3', -5'), 104.7 (s, C-10), 103.9 (d, C-3), 98.7 (d, C-6), 93.2 (d, C-8), 56.4 (q, 7-OCH~3~).

*Apigenin 5, 7-dimethyl ether (3)*: C~17~H~14~O~5~, yellow needle crystal; ^1^H NMR (500 MHz, C~5~D~5~N) δ: 7.97 (2H, d, *J* = 8.8 Hz, H-2', H-6'), 7.12 (2H, d, *J* = 8.8 Hz, H-3', H-5'), 6.97 (1H, s, H-3), 6.71 (1H, d, *J* = 2.0 Hz, H-8), 6.62 (1H, d, *J* = 2.0 Hz, H-6), 3.77 and 3.75 (6H, 2s, 2×-OCH~3~); ^13^C NMR (125 MHz, C~5~D~5~N) δ: 182.9 (s, C-4), 166.0 (s, C-7), 164.3 (s, C-2), 163.1 (s, C-4'), 162.8 (s, C-5), 158.2 (s, C-9), 128.7 (d, C-2', C-6'), 115.0 (d, C-3', -5'), 106.0 (s, C-10), 104.8 (d, C-3), 98.7 (d, C-6), 93.0 (d, C-8), 56.0 and 55.6 (q, 7-OCH~3~).

*Luteolin 7, 4'-dimethyl ether (4)*: C~17~H~14~O~6~, brown needle crystal; ^1^H NMR (500 MHz, CD~3~COCD~3~) δ: 7.59 (1H, d, *J* = 8.5 Hz, 1.8 Hz, H-6'), 7.52 (1H, d, *J* = 1.8 Hz, H-2'), 7.14 (1H, d, *J* = 8.6 Hz, H-5'), 6.73 (1H, d, *J* = 1.8 Hz, H-8), 6.69 (1H, s, H-3), 6.32 (1H, d, *J* = 1.7 Hz, H-6), 3.95 and 3.93 (6H, 2s, 2×-OCH~3~); ^13^C NMR (150 MHz, CD~3~COCD~3~) δ: 183.2 (s, C-4), 166.7 (s, C-7), 165.1 (s, C-5), 163.0 (s, C-2), 158.8 (s, C-9), 151.9 (s, C-4'), 147.9 (s, C-3'), 124.8 (s, C-1'), 119.9 (d, C-6'), 113.8 (d, C-5'), 112.5 (d, C-2'), 106.1 (s, C-10), 104.8 (d, C-3), 98.8 (d, C-6), 93.3 (d, C-8), 56.5 and 56.4 (q, 2×-OCH~3~).

*5, 7-Di-O-methylquercetin (5)*: C~17~H~14~O~7~, yellow crystal; ^1^H NMR (500 MHz, C~5~D~5~N) δ: 8.10 (1H, d, *J* = 8.5 Hz, H-6'), 7.23 (1H, s, H-2'), 7.06 (1H, d, *J* = 8.6 Hz, H-5'), 6.70 (1H, d, *J* = 1.7 Hz, H-8), 6.33 (1H, d, *J* = 1.7 Hz, H-6), 3.85 and 3.74 (6H, 2s, 2×-OCH~3~); ^13^C NMR (125 MHz, C~5~D~5~N) δ: 169.2 (s, C-4), 161.3 (s, C-7), 159.3 (s, C-5), 158.8 (s, C-9), 144.8 (s, C-2, -4), 143.1 (s, C-3'), 124.6 (s, C-3), 120.9 (s, C-1'), 118.0 (d, C-6'), 117.5 (d, C-5'), 114.4 (d, C-2'), 108.7 (s, C-10), 96.1 (d, C-6), 94.9 (d, C-8), 56.4 and 55.6 (q, 2×-OCH~3~).

*3'-Hydroxy-4', 5, 7-trimethoxy-flavone (6)*: C~18~H~16~O~6~, brown needle crystal; ^1^H NMR (500 MHz, C~5~D~5~N) δ: 8.03 (1H, d, *J* = 8.5 Hz, 1.8 Hz, H-6'), 7.91 (1H, d, *J* = 2.3 Hz, H-2'), 7.30 (1H, d, *J* = 8.6 Hz, H-5'), 7.03 (1H, s, H-3), 6.63 (1H, d, *J* = 2.2 Hz, H-8), 6.61 (1H, d, *J* = 2.2 Hz, H-6), 3.80, 3.76 and 3.60 (9H, 3s, 3×-OCH~3~); ^13^C NMR (125 MHz, C~5~D~5~N) δ: 182.8 (s, C-4), 165.9 (s, C-7), 164.7 (s, C-5), 162.7 (s, C-2), 158.1 (s, C-9), 152.1 (s, C-4'), 148.6 (s, C-3'), 129.0 (d, C-6'), 124.6 (s, C-1'), 118.9 (d, C-5'), 117.0 (d, C-2'), 112.2 (s, C-10), 103.8 (d, C-3), 98.6 (d, C-6), 92.8 (d, C-8), 60.4, 56.5 and 56.4 (q, 3×-OCH~3~).

3-(1, 3-benzodioxol-5-ylmethyl)-4-\[(3, 4-dimethoxyphenyl)methyl\]dihydro-, (3S-cis)-2(3H)-Furanone (7): C~21~H~22~O~6~, colorless oil, \[α\]20 D+67.8° (c = 0.11, MeOH); ^13^C NMR (100 MHz, CDC1~3~) δ: 178.5 (s, C-9), 149.0 (s, C-3'), 147.84 (s, C-3), 147.80 (s, C-4'), 146.4 (s, C-4), 131.3 (s, C-1), 130.4 (s, C-1'), 122.2 (d, C-6), 120.6 (d, C-6'), 111.6 (d, C-5'), 111.2 (d, C-5), 109.4 (d, C-2'), 108.1 (d, C-2), 101.0 (t, C-1''), 71.2 (t, C-9'), 55.9 (q, 3'-OCH~3~), 55.7 (q, 3-OCH~3~), 46.4 (d, C-8), 41.2 (d, C-8'), 38.2 (t, C-7'), 34.7 (t, C-7).

*4-\[(R)-1, 3-benzodioxol-5-ylhydroxymethyl\]-3-(1, 3-benzodioxol-5-ylmethyl) dihydro-, (3S, 4R)-2(3H)-Furanone (8)*: C~20~H~18~O~7~, colorless needle crystal, \[α\]20 D+54.7° (c = 0.23, CHCl~3~); ^1^H NMR (500 MHz, C~5~D~5~N) δ: 7.07 (1H, s, H-2'), 6.93 (1H, d, *J* = 7.8 Hz, H-5'), 6.86 (1H, d, *J* = 8.0 Hz, H-5), 6.78 (1H, d, *J* = 7.8 Hz, H-6'), 6.73 (1H, d, *J* = 7.9 Hz, H-2), 6.01 \~ 5.91 (4H, m, 2×-OCH~2~O-), 4.96 (1H, d, *J* = 4.9 Hz, H-7'), 4.31 \~ 4.20 (2H, m, H-9'), 3.26 \~ 3.04 (3H, m, H-7, H-8), 2.78 (1H, m, H-8'); ^13^C NMR (125 MHz, C~5~D~5~N) δ: 179.6 (s, C-9), 148.3 (s, C-3'), 148.1 (s, C-3), 147.3 (s, C-4'), 146.7 (s, C-4), 138.1 (s, C-1'), 132.4 (s, C-1), 123.2 (d, C-6), 119.6 (d, C-6'), 110.3 (d, C-5), 108.4 (d, C-5'), 108.3 (d, C-2), 107.0 (d, C-2'), 101.6 and 101.4 (2t, 2×-OCH~2~O-), 74.3 (d, C-7'), 69.7 (t, C-9'), 46.1 (d, C-8), 43.5 (d, C-8'), 35.8 (t, C-7).

*(-)-Dihydrosesamin (9)*: C~20~H~20~O~6~, colorless powder, \[α\]20 D+21.3° (c = 0.12, MeOH); ^1^H NMR (400 MHz, CDC1~3~) δ: 6.80 \~ 6.58 (6H, m, H-2', H-5', H-5, H-6', H-2), 5.91 \~ 5.89 (4H, m, 2×-OCH~2~O-), 4.75 (1H, d, *J* = 6.1 Hz, H-7), 4.00 \~ 3.62 (4H, m, H-9', H-9), 2.80 (1H, dd, *J* = 13.5 Hz, 5.0 Hz, H-7'b), 2.45 (1H, m, H-7'a), 2.45 (1H, dd, *J* = 13.4 Hz, 10.8 Hz, H-8), 2.26 (1H, m, H-8'); ^13^C NMR (100 MHz, CDC1~3~) δ: 179.6 (s, C-9), 148.3 (s, C-3'), 148.1 (s, C-3), 147.3 (s, C-4'), 146.7 (s, C-4), 138.1 (s, C-1'), 132.4 (s, C-1), 123.2 (d, C-6), 119.6 (d, C-6'), 110.3 (d, C-5), 108.4 (d, C-5'), 108.3 (d, C-2), 107.0 (d, C-2'), 101.6 and 101.4 (2t, 2×-OCH~2~O-), 74.3 (d, C-7'), 69.7 (t, C-9'), 46.1 (d, C-8), 43.5 (d, C-8'), 35.8 (t, C-7).

*Phenol, 4, 4'-\[(2R, 3S, 4S)-tetrahydro-2-methoxy-3, 4-furandiyl\]bis (methylene)\]bis\[2-methoxy- (10)*: C~21~H~26~O~6~, colorless oil, \[α\]20 D+71.4° (c = 0.15, MeOH); ^1^H NMR (400 MHz, CDCl~3~) δ: 6.82 (1H, d, *J* = 8.0 Hz, H-5'), 6.77 (1H, d, *J* = 7.2 Hz, H-5), 6.62 (1H, d, *J* = 1.6 Hz, H-2), 6.57 (1H, dd, *J* = 8.0, 1.6 Hz, H-6'), 6.53 (1H, d, *J* = 1.6 Hz, H-2'), 6.44 (1H, dd, *J* = 7.2, 1.6 Hz, H-6), 4.74 (1H, d, *J* = 1.0 Hz, H-9'), 4.04 (1H, t, *J* = 8.2 Hz, H-9b), 3.83 (3H, s, 3-OCH~3~), 3.82 (3H, s, 3'-OCH~3~), 3.67 (1H, t, *J* = 8.2 Hz, H-9a), 3.34 (3H, s, 9'-OCH~3~), 2.72 (1H, dd, *J* = 13.1, 6.9 Hz, H-7'b), 2.57 (1H, m, H-7b), 2.55 (1H, m, H-7a), 2.42 (1H, dd, *J* = 13.1, 6.9 Hz, H -7'a), 2.15 (1H, m, H-8), 2.15 (1H, m, H-8'); ^13^C NMR (125 MHz, CDC1~3~) δ: 146.5 (s, C-4'), 146.3 (s, C-4), 144.0 (s, C-3), 143.8 (s, C-3'), 132.9 (s, C-1'), 132.2 (s, C-1), 121.4 (d, C-6), 121.3 (d, C-6'), 114.3 (d, C-2'), 114.2 (d, C-5), 111.5 (d, C-2), 111.1 (d, C-5'), 105.6 (d, C-9'), 72.3 (t, C-9), 55.9 (q, 3-OCH~3~), 55.8 (q, 3'-OCH~3~), 54.5 (q, 9'-OCH~3~), 52.2 (d, C-8'), 43.3 (d, C-8), 39.3 (t, C-7'), 33.5 (t, C-7).

*4, 4'-dihydroxy-3, 3', 9-trimethoxy-9, 9'-epoxylignan (11)*: C~21~H~26~O~6~, colorless oil, \[α\]20 D-23.7° (c = 0.14, MeOH); ^1^H NMR (400 MHz, CDCl~3~) δ: 6.83 (1H, d, *J* = 8.0 Hz, H-5), 6.81 (1H, d, *J* = 7.8 Hz, H-5'), 6.68 (1H, dd, *J* = 7.8, 1.5 Hz, H-6'), 6.67 (1H, d, *J* = 1.5 Hz, H-2'), 6.64 (1H, d, *J* = 8.0 Hz, H-6), 6.60 (1H, s, H-2), 4.66 (1H, d, *J* = 3.6 Hz, H-9'), 3.99 (1H, t, *J* = 6.6 Hz, H-9b), 3.86 (3H, s, 3-OCH~3~), 3.86 (3H, s, 3'-OCH~3~), 3.59 (1H, t, *J* = 6.6 Hz, H-9a), 3.32 (3H, s, 9'-OCH~3~), 2.76 (1H, m, H-7'b), 2.73 (1H, m, H-7b), 2.52 (1H, m, H -7'a), 2.46 (1H, m, H-7a), 2.39 (1H, m, H-8'), 2.01 (1H, m, H-8); ^13^C NMR (125 MHz, CDC1~3~) δ: 146.5 (s, C-4'), 146.4 (s, C-4), 144.0 (s, C-3), 143.8 (s, C-3'), 132.5 (s, C-1'), 131.6 (s, C-1), 121.6 (d, C-6), 121.2 (d, C-6'), 114.1 (d, C-2'), 114.0 (d, C-5), 111.1 (d, C-2), 110.9 (d, C-5'), 110.1 (d, C-9'), 72.2 (t, C-9), 55.7 (q, 3-OCH~3~), 55.7 (q, 3'-OCH~3~), 54.7 (q, 9'-OCH~3~), 52.4 (d, C-8'), 45.8 (d, C-8), 39.3 (t, C-7'), 38.7 (t, C-7).

*(+)-1-Hydroxypinoresinol (12)*: C~20~H~22~O~7~, yellow powder, \[α\]20 D+33.6° (c = 0.10, MeOH); ^1^H NMR (400 MHz, CD~3~COCD~3~) δ: 7.16 (1H, d, *J* = 8.0 Hz, H-5'), 7.11 (1H, d, *J* = 2.0 Hz, H-2'), 7.08 (1H, dd, *J* = 8.0, 1.9 Hz, H-6''), 6.92 (1H, d, *J* = 8.0 Hz, H-5''), 6.91 (1H, dd, *J* = 8.0, 2.0 Hz, H-6'), 6.88 (1H, d, *J* = 1.9 Hz, H-2''), 4.88 (1H, s, H-2), 4.56 (1H, d, *J* = 6.8 Hz, H-6), 4.31 (1H, m, H-8a), 3.87 (1H, dd, *J* = 8.8, 7.5 Hz, H-4a), 3.85 (3H, s, 3-OCH~3~), 3.82 (3H, s, 3'-OCH~3~), 3.78 (1H, d, *J* = 8.9, 4.1 Hz, H-4b), 3.70 (1H, m, H-8b), 3.50 (1H, m, H-5); ^13^ C NMR (100 MHz, CD~3~COCD~3~) δ: 151.8 (s, C-3''), 148.5 (s, C-3'), 147.9 (s, C-4', C-4''), 132.9 (s, C-1''), 129.5 (s, C-1'), 120.5 (d, C-6'), 119.2 (d, C-6''), 115.15 (d, C-5''), 115.06 (d, C-5'), 111.4 (d, C-2'), 110.8 (d, C-2''), 91.1 (s, C-1), 88.4 (d, C-2), 86.6 (d, C-6), 73.7 (t, C-8), 71.4 (t, C-4), 61.8 (d, C-5), 56.2 and 56.1 (q, -OCH~3~).
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